Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- Section 2 Management Commentaries
- 18 Introduction to Management Commentaries
- 19 Management Commentary
- 20 Management Commentary
- 21 Management Commentary
- 22 Management Commentary
- 23 Management Commentary
- 24 Management Commentary
- 25 Management Commentary
- 26 Management Commentary
- 27 Management Commentary
- 28 Management Commentary
- 29 Management Commentary
- 30 Management Commentary
- 31 Management Commentary
- 32 Management Commentary
- 33 Management commentary
- 34 Management Commentary
- 35 Management Commentary
- 36 Management Commentary
- Section 3 Conclusion
- Index
- References
26 - Management Commentary
from Section 2 - Management Commentaries
Published online by Cambridge University Press: 17 December 2018
By
Edited by
Book contents
- Bipolar II Disorder
- Bipolar II Disorder
- Copyright page
- Dedication
- Contents
- Contributors
- Preface to the Third Edition
- Acknowledgements
- Section 1 Domain Chapters
- Section 2 Management Commentaries
- 18 Introduction to Management Commentaries
- 19 Management Commentary
- 20 Management Commentary
- 21 Management Commentary
- 22 Management Commentary
- 23 Management Commentary
- 24 Management Commentary
- 25 Management Commentary
- 26 Management Commentary
- 27 Management Commentary
- 28 Management Commentary
- 29 Management Commentary
- 30 Management Commentary
- 31 Management Commentary
- 32 Management Commentary
- 33 Management commentary
- 34 Management Commentary
- 35 Management Commentary
- 36 Management Commentary
- Section 3 Conclusion
- Index
- References
- Type
- Chapter
- Information
- Bipolar II DisorderModelling, Measuring and Managing, pp. 242 - 245Publisher: Cambridge University PressPrint publication year: 2019
References
Geddes, J.R., Gardiner, A., Rendell, J., et al. (2016). Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2×2 factorial randomised trial. The Lancet Psychiatry, 3, 31–9.CrossRefGoogle Scholar
Malhi, G.S., Bassett, D., Boyce, P., et al. (2015). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Australian & New Zealand Journal of Psychiatry, 49, 1087–206.CrossRefGoogle ScholarPubMed
Malhi, G.S., Berk, M., Morris, G., et al. (2017). Mixed mood: the not so united states? Bipolar Disorders, 19, 242–5.CrossRefGoogle Scholar
Malhi, G.S., Byrow, Y., Boyce, P., et al. (2016). Why the hype about subtype? Bipolar I, bipolar II–It's simply bipolar, through and through! Australian & New Zealand Journal of Psychiatry, 50, 303–6.CrossRefGoogle ScholarPubMed
Tohen, M., Gold, A.K., Sylvia, L.G., et al. (2017). Bipolar mixed features–results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study. Journal of Affective Disorders, 217, 183–9.Google Scholar
Van der Loos, M.L., Mulder, P.G., Hartong, E.G., et al. (2009). Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial. The Journal of clinical psychiatry, 70, 223–31.Google Scholar
Vázquez, G.H., Lolich, M., Cabrera, C., et al. (2017). Mixed symptoms in major depressive and bipolar disorders: a systematic review. Journal of Affective Disorders, 225, 756–60.Google Scholar
- 2
- Cited by